Form 4: Surgery Partners' Chief Strategy Officer Sells Shares to Cover Tax Obligations
SEC Form 4 Filing
Marissa Brittenham, Chief Strategy Officer of Surgery Partners, Inc., sold 1,284 shares of common stock on March 4, 2024, to satisfy tax withholding obligations related to vesting restricted stock.
Summary
- On March 4, 2024, Marissa Brittenham, the Chief Strategy Officer of Surgery Partners, Inc., sold 1,284 shares of the company's common stock.
- The sale was executed at a weighted average price of $30.17 per share.
- This transaction was done to cover Ms. Brittenham's tax withholding obligations associated with the vesting of restricted stock on March 2, 2024.
- Following the transaction, Ms. Brittenham still beneficially owns 39,768 shares of Surgery Partners' common stock.
Sentiment
Score: 6
Explanation: The document describes a routine transaction (stock sale for tax obligations) by a company executive. It's neutral in nature and doesn't suggest any significant positive or negative sentiment regarding the company's prospects.
Industry Context
Sales of shares to cover tax obligations upon vesting of restricted stock are a common practice among corporate executives. This transaction is a routine part of executive compensation and does not necessarily indicate a change in the executive's confidence in the company.
Key Dates
| Date | Description |
|---|---|
| 03/02/2024 | Restricted stock vested, triggering tax obligations. |
| 03/04/2024 | Date of stock sale transaction. |
| 03/06/2024 | Date of Form 4 filing. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.